Biomedicines | Free Full-Text | Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score - Yang - 2023 - Cancer Medicine - Wiley Online Library
:max_bytes(150000):strip_icc()/GettyImages-1389278061-ca025a5867e04ce18d7fc1b2ecba8ce2.jpg "Luminal B Breast Cancer: Symptoms, Diagnosis, and More")
Luminal B Breast Cancer: Symptoms, Diagnosis, and More
Frontiers | Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis
IJMS | Free Full-Text | How to Predict Metastasis in Luminal Breast Cancer? Current Solutions and Future Prospects
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer | npj Breast Cancer
Overall survival depends on tumor subtype and systemic treatment. a... | Download Scientific Diagram
Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study | Scientific Reports
Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes - Sereda - Translational Breast Cancer Research
Breast Cancer Subtypes And Prognosis | BCTT
Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer
:max_bytes(150000):strip_icc()/GettyImages-1164234982-17a305f7dbaf4f4fb29ca25003cde65b.jpg "Luminal A Breast Cancer: Causes, Diagnosis, and Treatment")
Luminal A Breast Cancer: Causes, Diagnosis, and Treatment
Molecular profiles of genomically High Risk ER+ HER2- breast cancer tumors classified as functionally Basal or Luminal B by the BluePrint - Agendia
Luminal breast cancer | BCTT
Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes | BMC Women's Health | Full Text
Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes | BMC Women's Health | Full Text
Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden | BMC Cancer | Full Text
Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes - Sereda - Translational Breast Cancer Research
Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer - ScienceDirect
Disease-free survival curves of luminal type A and B breast cancer. | Download Scientific Diagram
Triple negative breast cancer therapies nanomedicine - Inside Tx
Basal-like carcinoma - Wikipedia
Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer - ScienceDirect
Breast cancer survival in Mexico between 2007 and 2016 in women without social security: a retrospective cohort study - The Lancet Regional Health – Americas
